St. Jude Medical, Inc. (NYSE:STJ)
| CAPS Rating |
|
|---|---|
| Open | $42.49 |
| Previous Close | $42.93 |
| Daily Range | $42.18 - $42.79 |
| 52-Week Range | $32.13 - $54.18 |
| Market Cap | $14.10B |
| P/E Ratio | 14.10 |
| Dividend (Yield) | 0.84 (N/A) |
| Volume | 2,451,338 |
| Average Daily Volume | 0 |
STJ
VS S&P 500 (SPY)
How do you think STJ will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
STJ Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
STJ News and Commentary
- Earnings Scorecard: St. Jude - Analyst Blog – NASDAQ
- Positive Outcome on MDT's CoreValve - Analyst Blog – NASDAQ
- BSX Disappoints, Guidance Weak - Ahead of Wall Street – NASDAQ
- Expectation Reset - Medical Device Stocks Poised to Outperform – Blogs @ The Motley Fool
- Stock Buybacks Do Not Benefit Future Stock Peformance – Trefis
- Earnings Preview: Boston Scientific - Analyst Blog – NASDAQ
- MDT Advances in CoreValve US Trial - Analyst Blog – NASDAQ
- St. Jude Beats, Charges Hurt Net - Analyst Blog – NASDAQ
- St. Jude Medical Beats Up on Analysts Yet Again – The Motley Fool
- UPDATE: St Jude's Profit Falls As Heart-Rhythm Sales Decline – SmartMoney
- St Jude Medical 4Q Net Falls 21% As Heart-Rhythm Sales Decline – SmartMoney
- Earnings Preview: St. Jude - Analyst Blog – NASDAQ
- Has Medtronic Become the Perfect Stock? – The Motley Fool
- Zacks Bull and Bear of the Day Highlights: Caterpillar, NII Holdings, Lowe's Companies, Home Depot a – NASDAQ
- St. Jude Halts FAME II Enrollment - Analyst Blog – NASDAQ
- Medtronic's Endurant II in Europe - Analyst Blog – NASDAQ
- 2nd UPDATE: St Jude Therapy Shows Positive Results In Heart Stent Trial – SmartMoney
- UPDATE: St Jude Therapy Shows Positive Results In Heart Stent Trial – SmartMoney
- St Jude Therapy Shows Positive Results In Heart Stent Trial – SmartMoney
- Has St. Jude Medical Become the Perfect Stock? – The Motley Fool
RSS Headlines
Fool UK
